Hex-1-en-3-one
General Information
Chemical name | Hex-1-en-3-one |
CAS number | 1629-60-3 |
Flavouring type | substances |
FL No. | 07.161 |
Mixture | No |
Purity of the named substance at least 95% unless otherwise specified | |
Reference body | EFSA |
From webgate.ec.europa.eu
Computed Descriptors
Download SDF2D Structure | |
CID | 15395 |
IUPAC Name | hex-1-en-3-one |
InChI | InChI=1S/C6H10O/c1-3-5-6(7)4-2/h4H,2-3,5H2,1H3 |
InChI Key | JTHNLKXLWOXOQK-UHFFFAOYSA-N |
Canonical SMILES | CCCC(=O)C=C |
Molecular Formula | C6H10O |
Wikipedia | 1-hexen-3-one |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 98.145 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Complexity | 74.2 |
CACTVS Substructure Key Fingerprint | A A A D c c B g I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A C A S A g A A C A A A A A A C I A K B S A A A A A A A g A A A I A A E A A E g A A B I A A A A A A A A A g A A A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 17.1 |
Monoisotopic Mass | 98.073 |
Exact Mass | 98.073 |
XLogP3 | None |
XLogP3-AA | 1.4 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 7 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9833 |
Human Intestinal Absorption | HIA+ | 0.9958 |
Caco-2 Permeability | Caco2+ | 0.8472 |
P-glycoprotein Substrate | Non-substrate | 0.7314 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7207 |
Non-inhibitor | 0.8475 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8946 |
Distribution | ||
Subcellular localization | Plasma membrane | 0.5713 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8263 |
CYP450 2D6 Substrate | Non-substrate | 0.8848 |
CYP450 3A4 Substrate | Non-substrate | 0.6924 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6320 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9330 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9590 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8544 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9562 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7765 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7806 |
Non-inhibitor | 0.9498 | |
AMES Toxicity | AMES toxic | 0.7765 |
Carcinogens | Carcinogens | 0.6413 |
Fish Toxicity | High FHMT | 0.7858 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8820 |
Honey Bee Toxicity | High HBT | 0.7846 |
Biodegradation | Ready biodegradable | 0.8329 |
Acute Oral Toxicity | III | 0.6806 |
Carcinogenicity (Three-class) | Non-required | 0.6034 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.7674 | LogS |
Caco-2 Permeability | 1.6766 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.1907 | LD50, mol/kg |
Fish Toxicity | 1.2278 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.4257 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Alpha,beta-unsaturated carbonyl compounds - Alpha,beta-unsaturated ketones |
Direct Parent | Enones |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Enone - Acryloyl-group - Ketone - Organic oxide - Hydrocarbon derivative - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as enones. These are compounds containing the enone functional group, with the structure RC(=O)CR'. |
From ClassyFire